Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-a inhibitors
Por:
Palacios-Diaz, R, Sahuquillo-Torralba, A, Rocamora-Durán, V, de Unamuno-Bustos, B, Salavert-Lleti, M, Santos-Alarcón, S, Quintero, A, Garcías-Ladaria, J, Vila-Payeras, A, Martínez-Doménech, A, Mateu-Puchades, A, Nadal-Lladó, C, Botella-Estrada, R
Publicada:
1 may 2023
Ahead of Print:
1 abr 2023
Resumen:
|